secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001193125-23-064549
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics appoints Thomas McCourt and Darren Cline to Board of Directors
--------------------------------------------------------------------------------

- Board expanded from 8 to 10 members; McCourt (Class II) and Cline (Class I) appointed effective March 6, 2023.
- Both deemed independent; McCourt joins Compensation Committee, Cline joins Audit Committee.
- Each receives annual retainer of $40,000; McCourt $5,000 for Comp Committee, Cline $7,500 for Audit Committee.
- Each granted option to purchase 22,000 shares, vesting monthly over three years.
- Standard indemnification agreements entered into with both new directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523064549/0001193125-23-064549-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523064549/d479466d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-064549

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer